select trial semaglutide ppt Beyond obesity: Novo's re-defines cardiovascular risk management Full SELECT Results Affirm CV

The medication works through several complementary mechanisms to improve glycaemic control in adults with type 2 diabetes

Evidence-based benefits in real life Energy metabolism and active days L-Carnitine is used to support energy metabolism and fat utilisation

The two MHRA-approved injectable options currently available through The Care Pharmacy Weight Loss Clinic are Mounjaro (tirzepatide) and Wegovy (semaglutide)

"These results support the remarkable potential for people living with type 2 diabetes." In a 40-week Phase 3 randomized, double-blind, placebo-controlled trial for retatrutide, which included 537 participants, the drug showed average A1C reductions of up to 2% and participants lost an average of 36.6 pounds, or roughly 17% weight loss